AsOf

Recorded or changed on this day 2026-11-08

751–800 of 46,473 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 9,755,000,000 United States dollar
AbbVie cash and equivalents: 9,755,000,000 United States dollar, claim clm_87EEBCE86395 · ended · superseded by clm_A85CBBB42CDA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,767,110,083 shares
AbbVie shares outstanding: 1,767,110,083 shares, claim clm_8956DD97BC9C · ended · superseded by clm_20CB053D8AED · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 10,360,000,000 United States dollar
AbbVie total equity: 10,360,000,000 United States dollar, claim clm_897825A51216 · ended · superseded by clm_E994FFA98EDE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,766,473,359 shares
AbbVie shares outstanding: 1,766,473,359 shares, claim clm_89944DBAFE9E · ended · superseded by clm_5773E4734F59 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · net income · 4,863,000,000 United States dollar
AbbVie net income: 4,863,000,000 United States dollar, claim clm_89DC93530D47 · ended · superseded by clm_4595D4B200E2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 1,904,000,000 United States dollar
AbbVie quarterly operating income: 1,904,000,000 United States dollar, claim clm_8A7602897846 · ended · superseded by clm_78F42A193166 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,479,156,683 shares
AbbVie shares outstanding: 1,479,156,683 shares, claim clm_8A7E2D59A0AB · ended · superseded by clm_6FF261038A02 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 74,000,000 United States dollar
AbbVie cash and equivalents: 74,000,000 United States dollar, claim clm_8AB294800E36 · ended · superseded by clm_21E51F4C56F5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,591,699,124 shares
AbbVie shares outstanding: 1,591,699,124 shares, claim clm_8AD2A24EAFA5 · ended · superseded by clm_F79C518E8FAA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -8,566,000,000 United States dollar
AbbVie total equity: -8,566,000,000 United States dollar, claim clm_8B6884305CD5 · ended · superseded by clm_43A1D84452B5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 766,000,000 United States dollar
AbbVie quarterly net income: 766,000,000 United States dollar, claim clm_8C62E1009F26 · ended · superseded by clm_B36E746D71D8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 13,287,000,000 United States dollar
AbbVie cash and equivalents: 13,287,000,000 United States dollar, claim clm_8F4CF168CDB2 · ended · superseded by clm_D3C029303D23 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 8,015,000,000 United States dollar
AbbVie cash and equivalents: 8,015,000,000 United States dollar, claim clm_8F6D833F6BDE · ended · superseded by clm_CC9157DEB0B1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 27,008,000,000 United States dollar
AbbVie total assets: 27,008,000,000 United States dollar, claim clm_8F8F210CA067 · ended · superseded by clm_BF8527D581D8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 138,805,000,000 United States dollar
AbbVie total assets: 138,805,000,000 United States dollar, claim clm_8F94B2DED299 · ended · superseded by clm_456ABC3AB1E9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 4,329,000,000 United States dollar
AbbVie quarterly revenue: 4,329,000,000 United States dollar, claim clm_8FCC99AEFBF3 · ended · superseded by clm_9BDF5524D4D8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 12,182,000,000 United States dollar
AbbVie cash and equivalents: 12,182,000,000 United States dollar, claim clm_90B6D4FB71C7 · ended · superseded by clm_A2ED4BA1F89D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 147,972,000,000 United States dollar
AbbVie total assets: 147,972,000,000 United States dollar, claim clm_9166925B80EB · ended · superseded by clm_40C5FA2D2E2F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 9,201,000,000 United States dollar
AbbVie cash and equivalents: 9,201,000,000 United States dollar, claim clm_9196480FD2FF · ended · superseded by clm_D0F44FB1629D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 12,902,000,000 United States dollar
AbbVie quarterly revenue: 12,902,000,000 United States dollar, claim clm_91BA7A736154 · ended · superseded by clm_0285E2C1A7E7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 1,239,000,000 United States dollar
AbbVie quarterly net income: 1,239,000,000 United States dollar, claim clm_91D5FCA6D338 · ended · superseded by clm_55698570AC31 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 6,538,000,000 United States dollar
AbbVie quarterly revenue: 6,538,000,000 United States dollar, claim clm_91E1E8F4CFBF · ended · superseded by clm_57888AB73869 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,596,429,740 shares
AbbVie shares outstanding: 1,596,429,740 shares, claim clm_91E5B93BAAD8 · ended · superseded by clm_DA1BB2B2421A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 1,561,000,000 United States dollar
AbbVie quarterly net income: 1,561,000,000 United States dollar, claim clm_930D6A477C14 · ended · superseded by clm_7C59982F22F4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 66,099,000,000 United States dollar
AbbVie total assets: 66,099,000,000 United States dollar, claim clm_94513531556F · ended · superseded by clm_A31DA02730CF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 4,740,000,000 United States dollar
AbbVie cash and equivalents: 4,740,000,000 United States dollar, claim clm_94C338ACD4BE · ended · superseded by clm_F0AF41EB2CBC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 54,318,000,000 United States dollar
AbbVie revenue: 54,318,000,000 United States dollar, claim clm_94FBAE0710ED · ended · superseded by clm_46C087CADCC6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 3,295,000,000 United States dollar
AbbVie quarterly operating income: 3,295,000,000 United States dollar, claim clm_9573F19B5964 · ended · superseded by clm_CEA4039DB60E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,594,094,698 shares
AbbVie shares outstanding: 1,594,094,698 shares, claim clm_95C323AFFAFB · ended · superseded by clm_91E5B93BAAD8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 150,501,000,000 United States dollar
AbbVie total assets: 150,501,000,000 United States dollar, claim clm_9715BC353D4D · ended · superseded by clm_9166925B80EB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 28,657,000,000 United States dollar
AbbVie total assets: 28,657,000,000 United States dollar, claim clm_97E99E151E53 · ended · superseded by clm_42B02BB64DBB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 143,211,000,000 United States dollar
AbbVie total assets: 143,211,000,000 United States dollar, claim clm_988B5ED6F448 · ended · superseded by clm_1C492364766C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 960,000,000 United States dollar
AbbVie quarterly operating income: 960,000,000 United States dollar, claim clm_9A141AD4FB42 · ended · superseded by clm_12DF3E454E71 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 136,221,000,000 United States dollar
AbbVie total assets: 136,221,000,000 United States dollar, claim clm_9AD5695F0536 · ended · superseded by clm_E2D8EC5BAEAA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 133,898,000,000 United States dollar
AbbVie total assets: 133,898,000,000 United States dollar, claim clm_9AD5C074902A · ended · superseded by clm_BAF68C4E73F9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 3,998,000,000 United States dollar
AbbVie quarterly operating income: 3,998,000,000 United States dollar, claim clm_9B48C67E536A · ended · superseded by clm_C42D4D3906A5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 4,692,000,000 United States dollar
AbbVie quarterly revenue: 4,692,000,000 United States dollar, claim clm_9BDF5524D4D8 · ended · superseded by clm_A061D1ED53C1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 28,216,000,000 United States dollar
AbbVie revenue: 28,216,000,000 United States dollar, claim clm_9C790281A637 · ended · superseded by clm_67CC49EA52CC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 56,769,000,000 United States dollar
AbbVie total assets: 56,769,000,000 United States dollar, claim clm_9CD1CE44F2FC · ended · superseded by clm_0931D7B2DE2D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 5,944,000,000 United States dollar
AbbVie quarterly revenue: 5,944,000,000 United States dollar, claim clm_9DB567EABED1 · ended · superseded by clm_50CDB8FC3EC3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 91,199,000,000 United States dollar
AbbVie total assets: 91,199,000,000 United States dollar, claim clm_9EF733A037E6 · ended · superseded by clm_11536613CE39 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 3,613,000,000 United States dollar
AbbVie quarterly net income: 3,613,000,000 United States dollar, claim clm_A0327C4F8772 · ended · superseded by clm_B8246C4E0E64 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 4,658,000,000 United States dollar
AbbVie quarterly revenue: 4,658,000,000 United States dollar, claim clm_A061D1ED53C1 · ended · superseded by clm_3B799E473A52 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,591,540,513 shares
AbbVie shares outstanding: 1,591,540,513 shares, claim clm_A12CA3DA4AB9 · ended · superseded by clm_95C323AFFAFB · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · cash and equivalents · 10,774,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 2,456,000,000 United States dollar
AbbVie quarterly net income: 2,456,000,000 United States dollar, claim clm_A19F5E6ED2F1 · ended · superseded by clm_7A765E3288C2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 9,086,000,000 United States dollar
AbbVie cash and equivalents: 9,086,000,000 United States dollar, claim clm_A2860DB7C8A4 · ended · superseded by clm_A6644DA6B8CD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 9,746,000,000 United States dollar
AbbVie cash and equivalents: 9,746,000,000 United States dollar, claim clm_A2ED4BA1F89D · ended · superseded by clm_C8B5152DE66D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 65,664,000,000 United States dollar
AbbVie total assets: 65,664,000,000 United States dollar, claim clm_A31DA02730CF · ended · superseded by clm_B5248F34B0B8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 135,115,000,000 United States dollar
AbbVie total assets: 135,115,000,000 United States dollar, claim clm_A320A5717609 · ended · superseded by clm_0DE2793ECF77 · 1 source (1 primary) · conf 0.95

What the statuses mean